TRX Tranexamic Acid Ampoules 10x2ml - Institute BCN - Active ingredients

TRX Tranexamic Acid by Institute BCN | Professional brightening solution for hyperpigmentation, visible redness and dehydration wrinkles

For professionals. You can view the published Advanced Protocols by Institute BCN by clicking the link.

Professional Topical use

TRX is a sterile cosmetic for professional topical use formulated for aesthetic protocols aimed at improving the appearance of visible hyperpigmentation, evening out skin tone and adding radiance to the skin. Its composition incorporates tranexamic acid, one of the most prominent active ingredients in professional cosmetics for aesthetic work on dark spots of different origins, visible redness and wrinkles associated with skin dryness.

What TRX is

It is a brightening solution from the Institute BCN BCN Classics line, supplied in 2 ml ampoules. It is developed for use in the professional treatment room as part of professional depigmenting and brightening cosmetic protocols, especially when the aim is to visibly improve dark spots, post-inflammatory hyperpigmentation, visible vascular redness and uneven skin tone.

Professional cosmetic indication

Indicated for professional cosmetic protocols focused on hyperpigmentation and depigmenting treatments. It can also be integrated into aesthetic routines where the aim is to visibly improve melasma, solar lentigines, ephelides, post-acne marks, redness associated with rosacea or couperose, brownish dark circles and wrinkles caused by skin dryness.

Key cosmetic benefits

• Helps reduce and prevent the appearance of visible hyperpigmentation.
• Contributes to skin with a more even and radiant tone.
• Supports the aesthetic improvement of dark spots and visible redness.
• Supports professional cosmetic protocols for melasma, solar lentigines, post-acne marks and rosacea.
• Helps visibly brighten hyperpigmented areas or areas with visible redness.
• Helps improve the appearance of wrinkles caused by skin dryness.

Technical specifications

• Product TRX
• Brand Institute BCN
• Line BCN Classics
• Product type Professional brightening solution
• Format Ampoule
• Content per ampoule 2 ml
• Equivalent 0.07 fl. oz.
• Presentation Box of 10 ampoules
• Use Professional topical use
• Application External
• Treatments Hyperpigmentation and depigmenting
• Function Depigmenting solution with brightening effect

Main active ingredient

• Tranexamic acid Synthetic derivative of the amino acid lysine with cosmetic interest in visible pigmentation, the vascular component of dark spots and dehydration wrinkles.

Extended technical information

The technical documentation from Institute BCN presents TRX as a brightening solution based on tranexamic acid, a multifunctional active ingredient for cosmetic work on aesthetic skin concerns related to dark spots of different origins. The manufacturer highlights that this active ingredient acts not only on the melanin production process, but also on the release of the vascular and inflammatory component of skin dark spots.

TRX helps reduce and prevent the appearance of hyperpigmentation and improves the look of both resistant dark spots and spots with a translucent reddish tone associated with superficial blood vessels. For this reason, its application can be integrated into multiple professional cosmetic protocols, from melasma, solar lentigines or senile hyperkeratoses to rosacea, couperose, post-acne marks or alterations resulting from certain aesthetic treatments.

The technical sheet also highlights that tranexamic acid offers added value by acting on wrinkles caused by skin dryness. Overall, TRX is positioned as a depigmenting solution with a brightening and tone-correcting effect that helps restore uniformity and luminosity to skin with dark spots or visible redness.

Cosmetic objectives described in the technical documentation

• Correction of photoageing.
• Prevention of the appearance of hyperpigmentation such as melasma.
• Reduction in darkness in the area of brownish dark circles.
• Visible removal of spots resulting from inflammation and other lesions, such as acne.
• Reduction in the reddish tone of visible blood vessels.
• Cosmetic correction and prevention of rosacea and couperose.
• Evening out the skin tone to make it more uniform.
• Visible brightening of skin with some form of hyperpigmentation.
• Brightening of the complexion.
• Visible reduction of wrinkles caused by skin dryness.

Types of hyperpigmentation and visible alterations in which it can be integrated

• Melasma, chloasma or pregnancy mask.
• Dark spots during menopause or associated with contraceptives.
• Solar lentigo or age spots.
• Ephelides or freckles typical of phototypes I and II.
• Post-inflammatory hyperpigmentation.
• Visible marks resulting from acne.
• Rosacea, couperose, dilated capillaries or congested complexion.
• Alterations resulting from UV exposure, pollution, medicines or certain aesthetic treatments.

Cosmetic action of tranexamic acid

Tyrosinase inhibition

The technical documentation indicates that tranexamic acid decreases the tyrosinase activity of melanocytes by preventing plasminogen from binding to keratinocytes. This causes a reduction in prostaglandins and arachidonic acid, inflammatory mediators involved in melanogenesis, helping to reduce visible pigment production.

Plasmin inhibition

The manufacturer explains that plasmin leads to the production of arachidonic acid and the release of fibroblast growth factor, which in turn stimulates melanocyte growth. Tranexamic acid inhibits this pathway, reducing inflammatory mediators and reinforcing the inhibitory effect on the tyrosinase enzyme.

Inhibition of vascular factors

TRX reduces the expression of vascular endothelial growth factor and endothelin-1, generating an anti-angiogenic effect. From a cosmetic point of view, this translates into an action on blood vessel cells and a visible decrease in the excessive vascularisation characteristic of certain alterations such as couperose, rosacea or dilated capillaries.

Support for brownish dark circles and redness

The technical sheet indicates that tranexamic acid has the ability to chelate iron in haemosiderin, so it can be used cosmetically in certain types of hyperchromia, such as the visible whitening of brownish dark circles.

Support for dehydration wrinkles

The manufacturer highlights that tranexamic acid improves wrinkles that form as a consequence of skin dryness. This effect is related to a decrease in mast cell proliferation, an increase in fibroblasts and increased synthesis of type I collagen in dry skin.

Professional treatment room use profile

TRX is aimed at professionals seeking a specific depigmenting and brightening active ingredient for facial protocols. It is especially useful for skin with melasma, lentigines, post-inflammatory spots, visible redness, uneven tone, brownish dark circles and wrinkles associated with dry skin.

Professional treatment room applications

• Depigmenting cosmetic protocols.
• Professional treatments for melasma and solar lentigines.
• Routines for post-inflammatory hyperpigmentation and post-acne marks.
• Protocols for skin with visible redness, rosacea or couperose.
• Brightening treatments for uneven tone and dull skin.
• Combination with antioxidant, repairing, nourishing or restorative active ingredients according to professional judgement.

Treatments and blends described in the technical documentation

Nourishing

• Blend 1 TRX 2 ml + Polyvitamins 2 ml
• Blend 2 TRX 2 ml + Amino Acids 2 ml

Antioxidant

• Blend 1 TRX 2 ml + Glutathione 600 3 ml
• Blend 2 TRX 2 ml + Vitamin C 1 ml + Glutathione 600 2 ml

Repairing

• Blend TRX 2 ml + Sodium Pyruvate 2 ml

Restorative

• Blend TRX 2 ml + Glycolic Acid 2 ml

Hydrating and restructuring

• Blend TRX 2 ml + BCN Base 3 ml

Anti-inflammatory

• Blend TRX 2 ml + Dexpanthenol 3 ml

Brightening

• Blend TRX 2 ml + Vitamin C 3 ml

The technical documentation indicates that the recommended blends are for guidance and that skin needs may vary from one session to another. Professional assessment should determine the most suitable selection of active ingredients with synergistic action.

Expected cosmetic results

• Skin with a more even tone and a more radiant appearance.
• Visible improvement of hyperpigmentation and dark spots of different origins.
• Visible reduction of redness and the vascular component of certain alterations.
• Cosmetic support for melasma, lentigines, post-acne marks and brownish dark circles.
• Improvement in the appearance of fine wrinkles related to skin dryness.

Mesotherapy: products compatible with Dermapen and other beauty devices

Products compatible with Dermapen and other beauty devices are designed to be integrated into professional facial cosmetic protocols. They are compatible with techniques based on transdermal delivery systems.

Sterile non-injectable cosmetic for professional topical use, with a pharmaceutical-grade formulation, free from preservatives and additives.

Indicated for external application on the skin and compatible with professional cosmetic protocols for needle-free mesotherapy, superficial cosmetic microneedling and non-invasive transdermal delivery systems using professional equipment.

Its application must always be carried out according to the professional’s working protocol and in accordance with the intended use of the product.

Professional topical use

Product for professional topical use for external application on the skin within depigmenting, brightening, antioxidant and restructuring cosmetic protocols. Integration into the treatment, frequency of use and combination with other active ingredients must be defined according to professional assessment.

Indicative directions for use in a professional setting

Apply exclusively according to the professional protocol and the specialist’s technical judgement. The application technique, frequency of use, combination with other active ingredients and number of sessions must be adapted to the professional assessment of each case and to the aesthetic response observed.

Commercial presentation

Box with 10 ampoules of 2 ml each.